Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QCR4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 277 | 281 | PF00656 | 0.459 |
CLV_C14_Caspase3-7 | 9 | 13 | PF00656 | 0.686 |
CLV_NRD_NRD_1 | 333 | 335 | PF00675 | 0.419 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 333 | 335 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.734 |
CLV_PCSK_PC1ET2_1 | 246 | 248 | PF00082 | 0.418 |
CLV_PCSK_PC1ET2_1 | 74 | 76 | PF00082 | 0.723 |
CLV_PCSK_SKI1_1 | 215 | 219 | PF00082 | 0.400 |
CLV_PCSK_SKI1_1 | 233 | 237 | PF00082 | 0.453 |
DEG_APCC_DBOX_1 | 175 | 183 | PF00400 | 0.494 |
DEG_APCC_DBOX_1 | 341 | 349 | PF00400 | 0.421 |
DOC_CDC14_PxL_1 | 296 | 304 | PF14671 | 0.343 |
DOC_MAPK_DCC_7 | 294 | 304 | PF00069 | 0.368 |
DOC_MAPK_gen_1 | 219 | 228 | PF00069 | 0.373 |
DOC_MAPK_MEF2A_6 | 219 | 227 | PF00069 | 0.396 |
DOC_MIT_MIM_1 | 216 | 225 | PF04212 | 0.387 |
DOC_PP1_RVXF_1 | 231 | 238 | PF00149 | 0.355 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.624 |
DOC_USP7_MATH_1 | 43 | 47 | PF00917 | 0.539 |
DOC_WW_Pin1_4 | 204 | 209 | PF00397 | 0.475 |
DOC_WW_Pin1_4 | 246 | 251 | PF00397 | 0.420 |
LIG_14-3-3_CanoR_1 | 120 | 124 | PF00244 | 0.617 |
LIG_14-3-3_CanoR_1 | 137 | 143 | PF00244 | 0.386 |
LIG_14-3-3_CanoR_1 | 233 | 238 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 315 | 325 | PF00244 | 0.347 |
LIG_BRCT_BRCA1_1 | 233 | 237 | PF00533 | 0.321 |
LIG_BRCT_BRCA1_1 | 248 | 252 | PF00533 | 0.344 |
LIG_BRCT_BRCA1_1 | 269 | 273 | PF00533 | 0.447 |
LIG_BRCT_BRCA1_1 | 3 | 7 | PF00533 | 0.624 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.600 |
LIG_FHA_1 | 141 | 147 | PF00498 | 0.507 |
LIG_FHA_1 | 306 | 312 | PF00498 | 0.395 |
LIG_FHA_2 | 227 | 233 | PF00498 | 0.365 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.446 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.707 |
LIG_LIR_Gen_1 | 129 | 140 | PF02991 | 0.533 |
LIG_LIR_Gen_1 | 249 | 260 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 129 | 135 | PF02991 | 0.552 |
LIG_LIR_Nem_3 | 234 | 240 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 249 | 255 | PF02991 | 0.255 |
LIG_LIR_Nem_3 | 268 | 274 | PF02991 | 0.282 |
LIG_NRBOX | 221 | 227 | PF00104 | 0.358 |
LIG_PCNA_yPIPBox_3 | 137 | 146 | PF02747 | 0.516 |
LIG_SH2_CRK | 53 | 57 | PF00017 | 0.620 |
LIG_SH2_STAP1 | 39 | 43 | PF00017 | 0.691 |
LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.386 |
LIG_SH2_STAT5 | 240 | 243 | PF00017 | 0.420 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.634 |
LIG_SH3_3 | 16 | 22 | PF00018 | 0.648 |
LIG_SH3_3 | 294 | 300 | PF00018 | 0.407 |
LIG_SUMO_SIM_par_1 | 253 | 258 | PF11976 | 0.326 |
LIG_TRAF2_1 | 82 | 85 | PF00917 | 0.631 |
LIG_TRAF2_2 | 188 | 193 | PF00917 | 0.541 |
LIG_WW_1 | 50 | 53 | PF00397 | 0.600 |
MOD_CK1_1 | 130 | 136 | PF00069 | 0.447 |
MOD_CK1_1 | 231 | 237 | PF00069 | 0.334 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.412 |
MOD_CK1_1 | 37 | 43 | PF00069 | 0.746 |
MOD_CK2_1 | 226 | 232 | PF00069 | 0.358 |
MOD_CK2_1 | 306 | 312 | PF00069 | 0.411 |
MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.414 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.721 |
MOD_GlcNHglycan | 308 | 311 | PF01048 | 0.460 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.734 |
MOD_GlcNHglycan | 84 | 88 | PF01048 | 0.705 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.695 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.571 |
MOD_N-GLC_1 | 12 | 17 | PF02516 | 0.645 |
MOD_N-GLC_1 | 305 | 310 | PF02516 | 0.396 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.676 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.483 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.471 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.514 |
MOD_NEK2_1 | 265 | 270 | PF00069 | 0.358 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.315 |
MOD_NEK2_2 | 2 | 7 | PF00069 | 0.623 |
MOD_NEK2_2 | 344 | 349 | PF00069 | 0.464 |
MOD_PIKK_1 | 12 | 18 | PF00454 | 0.599 |
MOD_PKA_2 | 119 | 125 | PF00069 | 0.643 |
MOD_Plk_1 | 130 | 136 | PF00069 | 0.561 |
MOD_Plk_1 | 150 | 156 | PF00069 | 0.376 |
MOD_Plk_1 | 231 | 237 | PF00069 | 0.358 |
MOD_Plk_1 | 65 | 71 | PF00069 | 0.593 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.680 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.393 |
MOD_Plk_4 | 280 | 286 | PF00069 | 0.333 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.630 |
MOD_Plk_4 | 344 | 350 | PF00069 | 0.430 |
MOD_ProDKin_1 | 204 | 210 | PF00069 | 0.478 |
MOD_ProDKin_1 | 246 | 252 | PF00069 | 0.411 |
MOD_SUMO_rev_2 | 174 | 182 | PF00179 | 0.498 |
TRG_DiLeu_BaEn_1 | 177 | 182 | PF01217 | 0.496 |
TRG_DiLeu_BaLyEn_6 | 141 | 146 | PF01217 | 0.420 |
TRG_DiLeu_BaLyEn_6 | 298 | 303 | PF01217 | 0.353 |
TRG_ER_diArg_1 | 332 | 334 | PF00400 | 0.389 |
TRG_ER_diArg_1 | 47 | 50 | PF00400 | 0.630 |
TRG_Pf-PMV_PEXEL_1 | 162 | 167 | PF00026 | 0.497 |
TRG_Pf-PMV_PEXEL_1 | 81 | 85 | PF00026 | 0.631 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7C6 | Leptomonas seymouri | 70% | 83% |
A0A0S4J7N8 | Bodo saltans | 48% | 100% |
A0A1X0NWG2 | Trypanosomatidae | 54% | 100% |
A0A3S7WW26 | Leishmania donovani | 97% | 84% |
A4HYX5 | Leishmania infantum | 97% | 84% |
E9AII7 | Leishmania braziliensis | 90% | 90% |
E9AUS2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 82% |
V5B5H3 | Trypanosoma cruzi | 58% | 100% |